Myriad Genetics Inc (MYGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,900 | -20,600 | N/A | 8,800 | 1,900 |
| Depreciation Amortization | 37,700 | 18,200 | N/A | 54,600 | 36,300 |
| Income taxes - deferred | -6,800 | -5,100 | N/A | 3,000 | 2,300 |
| Accounts receivable | 13,600 | 16,700 | N/A | -27,000 | -900 |
| Accounts payable and accrued liabilities | -11,300 | -9,300 | N/A | -8,100 | -300 |
| Other Working Capital | -5,400 | 10,200 | N/A | -28,100 | -4,300 |
| Other Operating Activity | 15,000 | 5,700 | 0 | 49,000 | 10,600 |
| Operating Cash Flow | $13,900 | $15,800 | $N/A | $52,200 | $45,600 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,800 | -1,400 | N/A | -7,200 | -4,100 |
| Net Acquisitions | N/A | N/A | N/A | -278,500 | -278,500 |
| Purchase Of Investment | -45,000 | -23,100 | N/A | -57,000 | -36,600 |
| Sale Of Investment | 35,500 | 17,400 | N/A | 51,800 | 32,100 |
| Investing Cash Flow | $-14,300 | $-7,100 | $N/A | $-290,900 | $-287,100 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | N/A | N/A | 340,000 | 340,000 |
| Debt Repayment | -8,600 | -8,600 | N/A | -85,000 | -75,000 |
| Common Stock Issued | 1,300 | -400 | N/A | 6,500 | 4,500 |
| Common Stock Repurchased | 0 | N/A | N/A | -50,000 | -50,000 |
| Other Financing Activity | -3,900 | -3,300 | 0 | -1,400 | 0 |
| Financing Cash Flow | $-11,200 | $-12,300 | $N/A | $210,100 | $219,500 |
| Exchange Rate Effect | 1,100 | 300 | N/A | 2,600 | 1,700 |
| Beginning Cash Position | 93,200 | 93,200 | N/A | 110,900 | 110,900 |
| End Cash Position | 81,200 | 89,900 | N/A | 84,900 | 90,600 |
| Net Cash Flow | $-12,000 | $-3,300 | $N/A | $-26,000 | $-20,300 |
| Free Cash Flow | |||||
| Operating Cash Flow | 13,900 | 15,800 | N/A | 52,200 | 45,600 |
| Capital Expenditure | -4,800 | -1,400 | N/A | -7,200 | -4,100 |
| Free Cash Flow | 9,100 | 14,400 | 0 | 45,000 | 41,500 |